Regulation of complement 5a receptor expression in U937 cells by phorbol ester

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• The C5a receptor (C5aR) plays a crucial role in inflammatory responses.
• U937 cells, a human monoblastic cell line, are a model for studying monocyte/macrophage differentiation and receptor expression.

Purpose of the Study:

• To investigate the regulation of C5a receptor (C5aR) expression and function in U937 cells during differentiation.
• To elucidate the role of 1,25(OH)2D, cyclic adenosine monophosphate (cAMP), and protein kinase C (PKC) in modulating C5aR expression and binding affinity.

Main Methods:

• U937 cell differentiation induced by 1,25(OH)2D and cAMP.
• Assessment of C5aR expression and binding using radioligand assays.
• Investigation of PMA's effect on C5aR expression, affinity, and PKC activation.
• Analysis of microtubule depolymerizing agents' impact on C5aR binding.

Main Results:

• 1,25(OH)2D and cAMP synergistically induce C5aR expression in U937 cells.
• Phorbol myristate acetate (PMA) significantly augments C5aR induction but acutely downregulates C5aR binding in a dose- and time-dependent manner.
• PMA treatment alters C5aR affinity, with chronic exposure potentially upregulating gene expression.
• Microtubule depolymerizing agents also induce C5aR downregulation, suggesting a role for cytoskeletal elements.

Conclusions:

• PKC activation acutely limits macrophage response to C5a by downregulating C5aR binding.
• Chronic PMA treatment promotes C5aR expression, likely via enhanced gene expression, suggesting a complex regulatory role for PKC in C5aR modulation.